GlobeNewswire 上市公司公告·· 3 小时前AI 评分40
SRX Global 与全资 SPV CERO 1236 签署最终协议收购 CERo Therapeutics
SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies
AI 导读
SRX Global（NYSE American: SRXH）与全资 SPV CERO 1236 签署最终购买协议，收购细胞免疫疗法公司 CERo Therapeutics，后者将成其全资子公司。
来源：GlobeNewswire 上市公司公告 · globenewswire.com